Binding of perfluorooctanoic acid to rat and human plasma proteins

被引:313
作者
Han, X [1 ]
Snow, TA [1 ]
Kemper, RA [1 ]
Jepson, GW [1 ]
机构
[1] DuPont Haskell Lab Hlth & Environm Sci, Newark, DE 19714 USA
关键词
D O I
10.1021/tx034005w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Perfluorooctanoic acid (PFOA) is a commercially important organic fluorochemical and is considered to have a long half-life in human blood. In this paper, PFOA binding to rat and human plasma proteins was investigated. On the basis of results from size-exclusion chromatography and ligand blotting, most PFOA was in protein-bound form in male and female rat plasma, and the primary PFOA binding protein in plasma was serum albumin. PFOA binding to rat serum albumin (RSA) in the gas phase was observed by electrospray ionization MS. F-19 NMR experiments revealed that binding to RSA caused peak broadening and chemical shift changes of PFOA resonances, and on the basis of this observation, the dissociation constant was determined to be similar to0.3 mM. The dissociation constants for PFOA binding to RSA and human serum albumin (HSA) and the numbers of PFOA binding sites on RSA and HSA were also determined by a separation method using microdesalting columns. No significant difference was found between PFOA binding to RSA and PFOA binding to HSA. The dissociation constants for binding of PFOA to RSA or HSA and the numbers of PFOA binding sites were in the range of 0.3-0.4 mM and 6-9, respectively. On the basis of these binding parameters and the estimated plasma concentration of serum albumin, greater than 90% of PFOA would be bound to serum albumin in both rat and human blood.
引用
收藏
页码:775 / 781
页数:7
相关论文
共 55 条
  • [1] Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein
    Andersen, OM
    Petersen, HH
    Jacobsen, C
    Moestrup, SK
    Etzerodt, M
    Andreasen, PA
    Thogersen, HC
    [J]. BIOCHEMICAL JOURNAL, 2001, 357 (01) : 289 - 296
  • [2] [Anonymous], 1976, ACS S SERIES, DOI [DOI 10.1021/BK-1976-0028.CH007, DOI 10.1080/19440049.2011.617012]
  • [3] Ayed A, 1998, RAPID COMMUN MASS SP, V12, P339, DOI 10.1002/(SICI)1097-0231(19980415)12:7<339::AID-RCM163>3.0.CO
  • [4] 2-6
  • [5] Banks R.E., 1994, ORGANOFLUORINE CHEM
  • [6] FACILITATION BY SERUM-ALBUMIN OF RENAL TUBULAR SECRETION OF ORGANIC-ANIONS
    BESSEGHIR, K
    MOSIG, D
    ROCHRAMEL, F
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (03): : F475 - F484
  • [7] Characterization of a 95 kDa high affinity human high density lipoprotein-binding protein
    Bocharov, AV
    Vishnyakova, TG
    Baranova, IN
    Patterson, AP
    Eggerman, TL
    [J]. BIOCHEMISTRY, 2001, 40 (14) : 4407 - 4416
  • [8] BRCZYNSKI FJ, 1989, AM J PHYSIOL, V257, pG584
  • [9] PALMITATE UPTAKE BY HEPATOCYTE SUSPENSIONS - EFFECT OF ALBUMIN
    BURCZYNSKI, FJ
    CAI, ZS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (03): : G371 - G379
  • [10] Determination of the stability of the noncovalent phospholipid transfer protein-lipid complex by electrospray time-of-flight mass spectrometry
    de Brouwer, APM
    Versluis, C
    Westerman, J
    Roelofsen, B
    Heck, AJR
    Wirtz, KWA
    [J]. BIOCHEMISTRY, 2002, 41 (25) : 8013 - 8018